Interés Humano

Moderna proclama eficacia de su vacuna contra dos variantes de la covid-19

Indicó que trabajará para desarrollar una dosis adicional para aumentar aún más la protección contra mutaciones halladas en Sudáfrica y Reino Unido

(FILES) This file picture taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US biotechnology firm Moderna on January 25, 2021 said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE --
(FILES) This file picture taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US biotechnology firm Moderna on January 25, 2021 said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE -- JOEL SAGET
‌
‌

‌

‌
‌

‌

‌